r/r solid tumorsosteosarcomaWilms tumorneuroblastomasurvivinChildren’s National Hospital’s Institutional Review BoardWT1PRAMEDepartment of Defense Peer Reviewed Cancer Research Program Career Development Award
…d over 2 dose levels to 6 patients (age range 18-66 years) with r/r solid tumors were well-tolerated with no dose limiting toxicities, both alon…